Survival benefits of western and traditional Chinese medicine treatment for patients with pancreatic cancer

Medicine (United States)

Volumn 94, Issue 26, 2015, Pages

  Yang, Xue ^a   Hao, Jian ^a   Zhu, Cui Hong ^a   Niu, Yang Yang ^a   Ding, Xiu Li ^a   Liu, Chang ^a   Wu, Xiong Zhi ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; EVODIA FRUIT; HERBACEOUS AGENT; PAEONIA RADIX;

ADULT; AGED; ARTICLE; BRANCHLET; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER PROGNOSIS; CANCER SURVIVAL; CHINESE MEDICINE; CONTROLLED STUDY; ENDOTHELIUM CORNEUM GIGERIAE GALLI; EUPOLYPHAGA SEU STELEOPHAGA; FAECES TOGOPTERI; FEMALE; FOLIUM ARTEMISIAE ARGYI; FRUCTUS AKEBIAE; FRUCTUS GARDENIAE; FRUCTUS HERBA SPICA PRUNELLAE; FRUCTUS HORDEI GERMINATUS; FRUCTUS MELIAE TOOSENDAN; FRUIT; GECKO; HEDYOTIS; HERB; HERBA ARTEMISIAE SCOPARIAE; HERBA ASARI; HERBA HEDYOTIS; HERBA PLANTAGINIS; HERBA SCUTELLARIAE BARBATAE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; OVERALL SURVIVAL; PANCREAS CANCER; POLLEN TYPHAE; PRIORITY JOURNAL; RADIX ACONITI LATERALIS PREPARATA; RADIX ASTRAGALI SEU HEDYSARI; RADIX AUCKLANDIAE; RADIX ET RHIZOMA RHEI; RADIX LINDERAE; RADIX PHYTOLACCAE; RADIX PSEUDOSTELLARIAE; RADIX SCUTELLARIAE; RAMULUS CINNAMOMI; RHIZOMA CORYDALIS; RHIZOMA CURCUMAE; RHIZOMA ZINGIBERIS; RHIZOME; SEMEN COICIS; SOLANUM NIGRUM; SPORA LYGODII; SQUAMA MANIS; VERY ELDERLY; WESTERN MEDICINE; ADENOCARCINOMA; CHINA; EPIDEMIOLOGY; MIDDLE AGED; MORTALITY; PANCREATIC NEOPLASMS; PHYTOTHERAPY; RETROSPECTIVE STUDY;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHINA; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; PANCREATIC NEOPLASMS; PHYTOTHERAPY; RETROSPECTIVE STUDIES;

EID: 84942510268     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000001008     Document Type: Article

References (29)

1. Siegel R, Ma J, Zou Z, et al. Cancer statistics, 2014. CA Cancer J Clin. 2014;64:9-29.
2. Malvezzi M, Bertuccio P, Levi F, et al. European cancer mortality predictions for the year 2013. Ann Oncol. 2013;24:792-800.
3. Kelsen DP, Portenoy R, Thaler H, et al. Pain as a predictor of outcome in patients with operable pancreatic carcinoma. Surgery. 1997;122:53-59.
4. Shaib YH, Davila JA, El-Serag HB. The epidemiology of pancreatic cancer in the United States: changes below the surface. Aliment Pharmacol Ther. 2006;24:87-94.
5. Sener SF, Fremgen A, Menck HR, et al. Pancreatic cancer: a report of treatment and survival trends for 100, 313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg. 1999;189:1-7.
6. Vincent A, Herman J, Schulick R, et al. Pancreatic cancer. Lancet. 2011;378:607-620.
7. Pawlik TM, Laheru D, Hruban RH, et al. Evaluating the impact of a single-day multidisciplinary clinic on the management of pancreatic cancer. Ann Surg Oncol. 2008;15:2081-2088.
8. Yang GY, Wagner TD, Fuss M, et al. Multimodality approaches for pancreatic cancer. CA Cancer J Clin. 2005;55:352-367.
9. Lee YW, Chen TL, Shih YR, et al. Adjunctive traditional Chinese medicine therapy improves survival in patients with advanced breast cancer: a population-based study. Cancer. 2014;120:1338-1344.
10. Xu Y, Zhao AG, Li ZY, et al. Survival benefit of traditional Chinese herbal medicine (a herbal formula for invigorating spleen) for patients with advanced gastric cancer. Integr Cancer Ther. 2013;12:414-422.
11. Guo H, Liu JX, Xu L, et al. Traditional Chinese medicine herbal treatment may have a relevant impact on the prognosis of patients with stage IV adenocarcinoma of the lung treated with platinum-based chemotherapy or combined targeted therapy and chemotherapy. Integr Cancer Ther. 2011;10:127-137.
12. Man Y-N, Liu X-H, Wu X-Z. Chinese medicine herbal treatment based on syndrome differentiation improves the overall survival of patients with unresectable hepatocellular carcinoma. Chin J Integr Med. 2015;21:49-57.
13. Liszka L, Pajak J, Mrowiec S, et al. Age distribution patterns of patients with conventional ductal adenocarcinoma of the pancreas. A single-institution study of 580 cases re-evaluated using current histopathological diagnostic criteria. Pol J Pathol. 2010;61:65-77.
14. Li Y, Ellis K-L, Ali S, et al. Apoptosis-inducing effect of chemotherapeutic agents is potentiated by soy isoflavone genistein, a natural inhibitor of NF-kappaB in BxPC-3 pancreatic cancer cell line. Pancreas. 2004;28:e90-e95.
15. Ouyang H, Wang P, Meng Z, et al. Multimodality treatment of pancreatic cancer with liver metastases using chemotherapy, radiation therapy, and/or Chinese herbal medicine. Pancreas. 2011;40:120-125.
16. Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140:883-899.
17. Sorensen HT, Mellemkjaer L, Olsen JH, et al. Prognosis of cancers associated with venous thromboembolism. N Engl J Med. 2000;343:1846-1850.
18. Yang L, Yamagata N, Yadav R, et al. Cancer-associated immunodeficiency and dendritic cell abnormalities mediated by the prostaglan-din EP2 receptor. J Clin Invest. 2003;111:727-735.
19. Yu R, Hong H. Cancer Management with Chinese Medicine [M].World Scientific; 2012.
20. Ravikiran G, Raju A, Venugopal Y. Phytolacca americana: a review. Int J Res Pharm Biomed Sci. 2011;2:942-946.
21. Kuo CC, Chen HH, Chiang W. Adlay (yi yi; "soft-shelled job's tears"; the seeds of Coix lachryma-jobi L. var. ma-yuen Stapf) is a potential cancer chemopreventive agent toward multistage carcino-genesis processes. J Tradit Complement Med. 2012;2:267-275.
22. Donald G, Hertzer K, Eibl G. Baicalein-an intriguing therapeutic phytochemical in pancreatic cancer. Curr Drug targets. 2012;13:1772-1776.
23. Yin J-H, Shi W-D, Zhu X-Y, et al. Qingyihuaji formula inhibits progress of liver metastases from advanced pancreatic cancer xenograft by targeting to decrease expression of Cyr61 and VEGF. Integr Cancer Ther. 2012;11:37-47.
24. Wang P, Chen Z, Meng Z-Q, et al. Ski acts as therapeutic target of qingyihuaji formula in the treatment of SW1990 pancreatic cancer. Integr Cancer Ther. 2010;9:50-58.
25. Lu Y, Wu LQ, Dong Q, et al. Experimental study on the effect of Kang-Lai-Te induced apoptosis of human hepatoma carcinoma cell HepG2. Hepatobiliary Pancreat Dis Int. 2009;8:267-272.
26. Bao Y, Yuan Y, Xia L, et al. Neutral lipid isolated from endosperm of Job's tears inhibits the growth of pancreatic cancer cells via apoptosis, G2/M arrest, and regulation of gene expression. J Gastroenterol Hepatol. 2005;20:1046-1053.
27. Tatsumi K, Shinozuka N, Nakayama K, et al. Hochuekkito improves systemic inflammation and nutritional status in elderly patients with chronic obstructive pulmonary disease. J Am Geriatr Soc. 2009;57:169-170.
28. Ko K-M, Leon T, Mak D, et al. A characteristic pharmacological action of 'Yang-invigorating' Chinese tonifying herbs: enhancement of myocardial ATP-generation capacity. Phytomedicine. 2006;13:636-642.
29. Ko KM, Leung HY. Enhancement of ATP generation capacity, antioxidant activity and immunomodulatory activities by Chinese Yang and Yin tonifying herbs. Chin Med. 2007;2:3.